Skip to main content
Top
Published in: Diabetologia 11/2009

Open Access 01-11-2009 | Short Communication

Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals

Authors: F. M. Finucane, J. Luan, N. J. Wareham, S. J. Sharp, S. O’Rahilly, B. Balkau, A. Flyvbjerg, M. Walker, K. Højlund, J. J. Nolan, D. B. Savage, (on behalf of the European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Cardiovascular Disease Risk Study Group)

Published in: Diabetologia | Issue 11/2009

Login to get access

Abstract

Aims/hypothesis

Obesity is the dominant cause of insulin resistance. In adult humans it is characterised by a combination of adipocyte hypertrophy and, to a lesser extent, adipocyte hyperplasia. As hypertrophic adipocytes secrete more leptin and less adiponectin, the plasma leptin:adiponectin ratio (LAR) has been proposed as a potentially useful measure of insulin resistance and vascular risk. We sought to assess the usefulness of the LAR as a measure of insulin resistance in non-diabetic white adults.

Methods

Leptin and adiponectin levels were measured in 2,097 non-diabetic individuals from the Ely and European Group for the Study of Insulin Resistance (EGIR) Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study cohorts. LAR was compared with fasting insulin and HOMA-derived insulin sensitivity (HOMA-S) in all individuals and with the insulin sensitivity index (M/I) from hyperinsulinaemic–euglycaemic clamp studies in 1,226 EGIR RISC participants.

Results

The LAR was highly correlated with HOMA-S in men (r = −0.58, p = 4.5 × 10−33 and r = −0.65, p = 1.1 × 10−66 within the Ely and EGIR RISC study cohorts, respectively) and in women (r = −0.51, p = 2.8 × 10−36 and r = −0.61, p = 2.5 × 10−73). The LAR was also strongly correlated with the clamp M/I value (r = −0.52, p = 4.5 × 10−38 and r = −0.47, p = 6.6 × 10−40 in men and women, respectively), similar to correlations between HOMA-S and the M/I value.

Conclusions/interpretation

The leptin:adiponectin ratio is a useful measure of insulin resistance in non-diabetic white adults. These data highlight the central role of adipocyte dysfunction in the pathogenesis of insulin resistance. Given that variations between fasting and postprandial leptin and adiponectin levels tend to be small, the leptin to adiponectin ratio might also have potential value in assessing insulin sensitivity in the non-fasted state.
Appendix
Available only for authorised users
Literature
1.
go back to reference Badman MK, Flier JS (2007) The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 132:2103–2115CrossRefPubMed Badman MK, Flier JS (2007) The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 132:2103–2115CrossRefPubMed
2.
go back to reference Satoh N, Naruse M, Usui T et al (2004) Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27:2488–2490CrossRefPubMed Satoh N, Naruse M, Usui T et al (2004) Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27:2488–2490CrossRefPubMed
3.
go back to reference Zhuo Q, Wang Z, Fu P et al (2009) Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res Clin Pract 84:27–33CrossRefPubMed Zhuo Q, Wang Z, Fu P et al (2009) Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res Clin Pract 84:27–33CrossRefPubMed
4.
go back to reference Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A (2005) Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 48:1911–1918CrossRefPubMed Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A (2005) Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 48:1911–1918CrossRefPubMed
5.
go back to reference Semple RK, Soos MA, Luan J et al (2006) Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 91:3219–3223CrossRefPubMed Semple RK, Soos MA, Luan J et al (2006) Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 91:3219–3223CrossRefPubMed
6.
go back to reference Wallace TM, Matthews DR (2002) The assessment of insulin resistance in man. Diabet Med 19:527–534CrossRefPubMed Wallace TM, Matthews DR (2002) The assessment of insulin resistance in man. Diabet Med 19:527–534CrossRefPubMed
7.
go back to reference Williams DR, Wareham NJ, Brown DC et al (1995) Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 12:30–35CrossRefPubMed Williams DR, Wareham NJ, Brown DC et al (1995) Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 12:30–35CrossRefPubMed
8.
go back to reference Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Cardiovascular Disease Risk): I. Methodology and objectives. Diabetologia 47:566–570CrossRefPubMed Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Cardiovascular Disease Risk): I. Methodology and objectives. Diabetologia 47:566–570CrossRefPubMed
9.
go back to reference Gray SL, Vidal-Puig AJ (2007) Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutr Rev 65:S7–12CrossRefPubMed Gray SL, Vidal-Puig AJ (2007) Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutr Rev 65:S7–12CrossRefPubMed
10.
go back to reference Cinti S, Mitchell G, Barbatelli G et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347–2355CrossRefPubMed Cinti S, Mitchell G, Barbatelli G et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347–2355CrossRefPubMed
11.
go back to reference Hung YJ, Chu NF, Wang SC et al (2006) Correlation of plasma leptin and adiponectin with insulin sensitivity and beta-cell function in children—the Taipei Children Heart Study. Int J Clin Pract 60:1582–1587CrossRefPubMed Hung YJ, Chu NF, Wang SC et al (2006) Correlation of plasma leptin and adiponectin with insulin sensitivity and beta-cell function in children—the Taipei Children Heart Study. Int J Clin Pract 60:1582–1587CrossRefPubMed
12.
go back to reference Oda N, Imamura S, Fujita T et al (2008) The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metab Clin Exper 57:268–273 Oda N, Imamura S, Fujita T et al (2008) The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metab Clin Exper 57:268–273
13.
go back to reference Semple RK, Halberg NH, Burling K et al (2007) Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56:1712–1717CrossRefPubMed Semple RK, Halberg NH, Burling K et al (2007) Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56:1712–1717CrossRefPubMed
14.
go back to reference Considine RV, Premkumar A, Reynolds JC, Sebring NG, Ricks M, Sumner AE (2008) Adiponectin and leptin in African Americans. Obesity (Silver Spring) 16:428–434CrossRef Considine RV, Premkumar A, Reynolds JC, Sebring NG, Ricks M, Sumner AE (2008) Adiponectin and leptin in African Americans. Obesity (Silver Spring) 16:428–434CrossRef
15.
go back to reference Gavrila A, Peng CK, Chan JL, Mietus JE, Goldberger AL, Mantzoros CS (2003) Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metabol 88:2838–2843CrossRef Gavrila A, Peng CK, Chan JL, Mietus JE, Goldberger AL, Mantzoros CS (2003) Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metabol 88:2838–2843CrossRef
Metadata
Title
Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals
Authors
F. M. Finucane
J. Luan
N. J. Wareham
S. J. Sharp
S. O’Rahilly
B. Balkau
A. Flyvbjerg
M. Walker
K. Højlund
J. J. Nolan
D. B. Savage
(on behalf of the European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Cardiovascular Disease Risk Study Group)
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 11/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1508-3

Other articles of this Issue 11/2009

Diabetologia 11/2009 Go to the issue